Kleanthis G. Xanthopoulos, Director at APRICUS BIOSCIENCES, INC. (APRI), sold 2,864 shares at $2.52 ($7K) on 2013-06-21, disclosed to the SEC on 2013-06-21.
Scheduled sale ($7k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RGLS | SELL | 2015-03-05 | $1.8M | — | Filing → |
| RGLS | SELL | 2015-03-03 | $1K | — | Filing → |
| RGLS | SELL | 2015-02-03 | $112K | — | Filing → |